SCHEDULE 14A INFORMATION
                Proxy Statement Pursuant to Section 14(a) of the
                         Securities Exchange Act of 1934

Filed by the Registrant...............................................[X]
Filed by a Party other than the Registrant............................[ ]

Check the appropriate box:

[ ] Preliminary Proxy Statement
[ ] Confidential,  for  Use  of the  Commission  Only  (as  permitted  by  Rule
    14a-6(e)(2)) 
[ ] Definitive Proxy Statement 
[X] Definitive  Additional Materials
[ ] Soliciting Material Pursuant to ss. 240.14a-11(c) or ss. 240.14a-12

                                OrthoLogic Corp.
    ------------------------------------------------------------------------
                (Name of Registrant As Specified In Its Charter)


     (Name of Person(s) Filing Proxy Statement if other than the Registrant)
    ------------------------------------------------------------------------
               Payment of Filing Fee (Check the appropriate box):

[ ] $125 per Exchange Act Rules 0-11(c)(1)(ii),  14a-6(i)(1), 14a-6(i)(2)
    or Item 22(a)(2) of Schedule 14A.
[ ] $500  per  each  party  to  the  controversy  pursuant  to Exchange Act Rule
    14a-6(i)(3).
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

         1)      Title of each class of securities to which transaction applies:

                 --------------------------------------------------------------
         2)      Aggregate number of securities to which transaction applies:

                 --------------------------------------------------------------
         3)      Per  unit  price  or other  underlying  value  of  transaction
                 computed  pursuant  to  Exchange  Act Rule 0-11 (Set forth the
                 amount on which the filing fee is calculated  and state how it
                 was determined):

                 --------------------------------------------------------------
         4)      Proposed maximum aggregate value of transaction:

                 --------------------------------------------------------------
         5)      Total fee paid:

                 --------------------------------------------------------------
[X]      Fee paid previously with preliminary materials.
[ ]      Check  box  if any part of the fee is offset as  provided  by  Exchange
         Act Rule  0-11(a)(2)  and identify the filing for which the  offsetting
         fee was paid  previously.  Identify the previous filing by registration
         statement number, or the Form or Schedule and the date of its filing.
         1)       Amount Previously Paid:
                                         ---------------------------------------
         2)       Form, Schedule or Registration Statement No.:
                                                               -----------------
         3)       Filing Party:
                               -------------------------------------------------
         4)       Date Filed:
                             ---------------------------------------------------

     [LOGO]

2850 South 36th Street
Phoenix, Arizona 85034
- --------------------------------------------------------------------------------

                           PROXY STATEMENT SUPPLEMENT
                         ANNUAL MEETING OF STOCKHOLDERS
                                   May 3, 1996
                          Adjourned until May 17, 1996

Dear Stockholders:

         During the Annual  Meeting of  Stockholders  of OrthoLogic  Corp.  (the
"Company") held on May 3, 1996, the Company's nominees were elected as directors
and the other  proposals  considered  were adopted,  except that the meeting was
adjourned to a later date before  action on Proposal 2 regarding an amendment to
the  Company's  Stock  Option Plan (the "Plan") to increase the number of shares
available  for grant of options under the Plan by 600,000  shares.  Stockholders
will  consider  Proposal 2 on Friday,  May 17, 1996 at 9:00 am local time at the
executive  offices of the  Company,  2850 South 36th  Street,  Phoenix,  Arizona
85034.  The following  information  supplements  the  description  of Proposal 2
contained in the Proxy  Statement  dated March 25, 1996 (the "Proxy  Statement")
that was previously mailed to you.

         After May 3, 1996,  the Board of Directors  amended the Plan to provide
that  neither  the Board of  Directors  nor the  Plan's  administrators  may (i)
reprice  outstanding options or (ii) accept the surrender of outstanding options
in conjunction with the grant of new options in substitution for the surrendered
options at an exercise  price  lower than the price of the options  surrendered.
This  amendment  to the Plan can be  changed  further  only if both the Board of
Directors and stockholders consent.  While the Board of Directors did not intend
to reprice outstanding  options, the Board adopted this amendment in response to
stockholder inquiries.

         The Board of Directors  unanimously  recommends  that the  stockholders
vote FOR approval of Proposal 2. Stock  options play a key role in the Company's
ability to recruit, reward and retain executives and key employees.  The Company
believes that equity-based  incentive  programs help insure a tight link between
the  interests of its  stockholders  and  employees,  and enhance the  Company's
ability to continue  recruiting and retaining top talent.  The Company  believes
that the continued  operation of the Plan necessitates an increase in the shares
available for grant under the Plan.

         In addition to those option  grants  described in the Proxy  Statement,
the following  option grants are contingent  upon approval of Proposal 2 because
they represent grants in excess of the current Plan  limitation:  (i) the May 3,
1996 grant of options to Allen R.  Dunaway,  the  Company's  Vice  President and
Chief Financial Officer, to purchase 30,000 shares of the Company's Common Stock
at $34.75; (ii) the May 3, 1996 automatic grant of options to purchase shares of
the Company's  Common Stock to members of the Board of  Director's  compensation
committee  (12,000 shares to Fredric Feldman and 6,000 shares to George A. Oram,
Jr.);  and (iii) the March 28, 1996 grant of options to  Nicholas A. Skaff,  the
Company's  Vice  President,  Managed  Care,  to purchase  100,000  shares of the
Company's  Common Stock at $23.375.  Accordingly,  the  optionees  named in this
paragraph have a substantial interest in the passage of Proposal 2. Please refer
to the Proxy Statement for additional information with respect to Proposal 2.

         In addition to the proxy  solicitation  methods  described in the Proxy
Statement,  the Company  has engaged  Corporate  Investor  Communications,  Inc.
("CIC")  to  solicit  proxies  regarding  Proposal  2 via  the  mails,  personal
interview, telephone and telegram. The costs associated with CIC's solicitation,
consisting of $2,000 plus expenses, will be borne by the Company.

         In the event that you have  already  returned  your  properly  executed
proxy card, your proxy will be voted in accordance  with the directions  therein
at the re-convened meeting on May 17, 1996. If you wish to receive another proxy
card or copy of the Proxy  Statement,  please  call the  Company's  Director  of
Investor Relations, Richard Cartwright, at (602) 437-5520.

                                             By order of the Board of Directors,

                                             Allan M. Weinstein
                                             Chairman
Phoenix, Arizona
May 7, 1996